Notice Information
Notice Title
DAP C - Tier II Community Urology and Gynaecology services - 27-28
Notice Description
The community dermatology service is currently delivered by Mayflower Healthcare Alliance (MHA). This contract was passed to Essex ICB from NHS Hertfordshire and West Essex ICB as part of the ICB reorganisations in April 2026. It provides community-based dermatology services for the local population. Mayflower Healthcare Alliance has an established role in delivering dermatology care, supporting timely access to specialist assessment and treatment outside of the acute setting. This contract focuses on the delivery of community dermatology services, helping to manage patient demand closer to home and reducing pressures on secondary care providers where clinically appropriate. The service forms part of the wider dermatology pathway and works collaboratively with acute providers to ensure patients requiring specialist or hospital-based interventions are referred appropriately. The commissioning responsibility for this contract transferred to Essex ICB as part of the ICB reorganisation in April 2026. The contract is indicative and based on the 26/27 activity and for the purposes of clarity the value will be subject to the national inflator/deflator calculations. The relevant authority determined that Direct Award Process C applies because Mayflower Healthcare Alliance is the existing provider, the existing contract is due to end, the proposed contracting arrangements are not changing considerably, and the provider is satisfying the existing contract and is likely to satisfy the proposed contract to a sufficient standard.
Lot Information
Lot 1
The community dermatology service is currently delivered by Mayflower Healthcare Alliance (MHA). This contract was passed to Essex ICB from NHS Hertfordshire and West Essex ICB as part of the ICB reorganisations in April 2026. It provides community-based dermatology services for the local population. Mayflower Healthcare Alliance has an established role in delivering dermatology care, supporting timely access to specialist assessment and treatment outside of the acute setting. This contract focuses on the delivery of community dermatology services, helping to manage patient demand closer to home and reducing pressures on secondary care providers where clinically appropriate. The service forms part of the wider dermatology pathway and works collaboratively with acute providers to ensure patients requiring specialist or hospital-based interventions are referred appropriately. The commissioning responsibility for this contract transferred to Essex ICB as part of the ICB reorganisation in April 2026. The contract is indicative and based on the 26/27 activity and for the purposes of clarity the value will be subject to the national inflator/deflator calculations. The relevant authority determined that Direct Award Process C applies because Mayflower Healthcare Alliance is the existing provider, the existing contract is due to end, the proposed contracting arrangements are not changing considerably, and the provider is satisfying the existing contract and is likely to satisfy the proposed contract to a sufficient standard. The providers have been assessed against the criteria specified for this DAP C process: Quality & Innovation 40%. Quality should be the primary consideration because community dermatology is a specialist clinical service that requires accurate assessment, diagnosis, treatment and referral within an agreed clinical pathway. The service must consistently deliver safe, evidence-based care, provide timely access to specialist dermatology expertise, ensure appropriate triage and management of referrals, and support patients to manage long-term skin conditions closer to home. High-quality delivery is directly linked to improved patient outcomes, reduced waiting times, increased patient satisfaction, and a reduction in unnecessary referrals to secondary care, ensuring specialist acute services are reserved for patients with the most complex needs. Value 30%. It is a statutory duty to ensure the best use of public resources, therefore value has the second highest weighting Integration, Collaboration & Service Sustainability 15%, It is essential for good collaboration between provider, primary and secondary care Access Health Inequalities and Choice 10%; Access to community services are important to ensure not all patients are referred into an acute setting where appropriate Social Value 5%. Although the main focus of the specialist fertility service is to provide healthcare, a weighting of 5% has been allocated to reflect the ICB priority towards the importance of social value Key criteria were specified, and assessment against each criterion was assessed based as above and on the current service delivery model and performance. and the supplier meets all the requirements specified to the satisfaction of the ICB, and it is expected that they will satisfy the requirements of the new contract. NHS Essex Integrated Care Board (the Authority) intends to award a contract for the provision of Tier II Dermatology Services to the existing provider named above following Direct Award Process C under the Health Care Services (Provider Selection Regime) Regulations 2023.
Procurement Information
This is a Direct Award Process C intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For avoidance of doubt, the provisions of the Public Contract Regulations 2015 and Procurement Act do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by midnight Tuesday, 17 November 2026. The contract has not yet formally been awarded, this notice serves as an intention to award under PSR. The Authority has undertaken an appropriate and proportionate review of declarations and is satisfied that effective arrangements are in place to identify and manage any actual, potential, or perceived conflicts of interest. Where relevant, mitigation measures have been applied to ensure that no conflict is capable of conferring any undue advantage or disadvantage. On this basis, the Authority is satisfied that no conflict of interest has adversely affected, or is capable of adversely affecting, the integrity of the procurement. The provider has been assessed against the criteria specified for this DAP C process: Quality & Innovation 40%. Quality should be the primary consideration because community dermatology is a specialist clinical service that requires accurate assessment, diagnosis, treatment and referral within an agreed clinical pathway. The service must consistently deliver safe, evidence-based care, provide timely access to specialist dermatology expertise, ensure appropriate triage and management of referrals, and support patients to manage long-term skin conditions closer to home. High-quality delivery is directly linked to improved patient outcomes, reduced waiting times, increased patient satisfaction, and a reduction in unnecessary referrals to secondary care, ensuring specialist acute services are reserved for patients with the most complex needs. Value 30%. It is a statutory duty to ensure the best use of public resources, therefore value has the second highest weighting Integration, Collaboration & Service Sustainability 15%, It is essential for good collaboration between provider, primary and secondary care Access Health Inequalities and Choice 10%; Access to community services are important to ensure not all patients are referred into an acute setting where appropriate Social Value 5%. Although the main focus of the specialist fertility service is to provide healthcare, a weighting of 5% has been allocated to reflect the ICB priority towards the importance of social value Key criteria were specified, and assessment against each criterion was assessed based as above and on the current service delivery model and performance. and the supplier meets all the requirements specified to the satisfaction of the ICB, and it is expected that they will satisfy the requirements of the new contract. NHS Essex Integrated Care Board (the Authority) intends to award a contract for the provision of Tier II Dermatology Services to the existing provider named above following Direct Award Process C under the Health Care Services (Provider Selection Regime) Regulations 2023.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-07b310
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/107694-2026
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
-
- CPV Codes
85110000 - Hospital and related services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £819,043 £500K-£1M
Notice Dates
- Publication Date
- 12 Nov 20264 days ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS Essex Integrated Care Board
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- CHELMSFORD
- Postcode
- CM1 1QH
- Postcode Area
- Chelmsford
- Country
- England
-
- Major Region (ITL 1)
- TLH East (England)
- Basic Region (ITL 2)
- TLH3 Essex
- Small Region (ITL 3)
- TLH36 Heart of Essex
- Delivery Location
- TLH3 Essex
-
- Local Authority
- Chelmsford
- Electoral Ward
- Moulsham and Central
- Westminster Constituency
- Chelmsford
Further Information
Notice URLs
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.